Cover Image

Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study

In recent years several antibodies against citrullinated peptides (ACPAs) have been identified in patients with rheumatoid arthritis (RA) and their pathogenic, diagnostic and prognostic significance is under intense investigation. Among ACPAs, those targeting citrullinated alpha enolase (anti-CEP1)...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Alunno (Author), O. Bistoni (Author), F. Pratesi (Author), F. Topini (Author), I. Puxeddu (Author), V. Valentini (Author), G. Cafaro (Author), E. Bartoloni (Author), P. Migliorini (Author), R. Gerli (Author)
Format:	Book
Published:	PAGEPress Publications, 2018-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The onset site of rheumatoid arthritis: the joints or the lung?
by: G. Cafaro, et al.
Published: (2016)

Extra-articular rheumatoid arthritis
by: E. Marcucci, et al.
Published: (2018)

Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019)

Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications
by: Alessia Alunno, et al.
Published: (2015)

Diagnostic effectiveness of anti-citrullinated peptides antibodies of second and third generations for rheumatoid arthritis
by: Goitybell Martínez Téllez, et al.
Published: (2018)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
by: Bo Li, et al.
Published: (2008)

Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis
by: G.L. Erre, et al.
Published: (2004)

Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis
by: G. Ferraccioli, et al.
Published: (2011)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
by: Pit Hui Lew, et al.
Published: (2021)

Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis
by: G. Valesini, et al.
Published: (2011)

Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands
by: A. Alunno, et al.
Published: (2016)

The study of tempromandibular joint disorders and anti-cyclic citrullinated peptide antibodies in serum and saliva of patients with rheumatoid arthritis
by: Raya M Khidhir, et al.
Published: (2014)

The clinical spectrum of primary Sjögren's syndrome: beyond exocrine glands
by: M.C. Leone, et al.
Published: (2017)

Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren's syndrome
by: Horino Taro, et al.
Published: (2022)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
by: Guseinova D, et al.
Published: (2008)

Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations
by: E. Bartoloni Bocci, et al.
Published: (2011)

The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis
by: Xuan Tang, et al.
Published: (2021)

Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels
by: Diana Castillo-Martínez, et al.
Published: (2017)

Discriminant Analysis of Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide, and C-Reactive Protein for Rheumatoid Arthritis Patients
by: Ausaf Ahmad, et al.
Published: (2017)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo Anne E, et al.
Published: (2012)

Anti-alpha-fodrin antibodies in patients with Sjögren's syndrome secondary to rheumatoid arthritis
by: Renato Nisihara, et al.

The Role of α-Enolase on the Production of Interleukin (IL)-32 in Con A-Mediated Inflammation and Rheumatoid Arthritis (RA)
by: Hyejung Jo, et al.
Published: (2024)

Correlation between anti-cyclic citrullinated peptide antibodies and the severity of clinical manifestation, laboratory manifestation, and radiological joint destruction in rheumatoid arthritis patients
by: Mat Suwito, et al.
Published: (2018)

Onset of polyarticular juvenile idiopathic arthritis with both anti-cyclic citrullinated peptide antibodies and rheumatoid factor in a 3-year-old girl
by: Yasui Kozo, et al.
Published: (2012)

CD3D, GZMK, and KLRB1 Are Potential Markers for Early Diagnosis of Rheumatoid Arthritis, Especially in Anti-Citrullinated Protein Antibody-Negative Patients
by: Junqin Lu, et al.
Published: (2021)

Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus
by: E. Bartoloni Bocci, et al.
Published: (2011)

Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity
by: F. Ragni Alunni, et al.
Published: (2011)

Anti-chromatin antibodies in juvenile rheumatoid arthritis
by: F. Ingegnoli, et al.
Published: (2003)

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
by: Dehlendorf Amanda B, et al.
Published: (2011)

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
by: Gilliam Brooke E, et al.
Published: (2012)

Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway
by: Changjun Lv, et al.
Published: (2023)

In silico-based identification of human α-enolase inhibitors to block cancer cell growth metabolically
by: Lung J, et al.
Published: (2017)

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
by: Ilaria Puxeddu, et al.
Published: (2017)

Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
by: C. Perricone, et al.
Published: (2024)

Accuracy and standardization of diagnostic methods for the detection of antibodies to citrullinated peptides
by: M. Tampoia, et al.
Published: (2011)

A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib
by: F.M. Mariani, et al.
Published: (2024)

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
by: Salugina SO, et al.
Published: (2008)

Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpoint
by: A. Colangelo, et al.
Published: (2023)